Nomura Securities Starts Galapagos NV (GLPG) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Credit Suisse Starts Galapagos NV (GLPG) at Outperform
June 8, 2015 8:27 AM EDTCredit Suisse initiates coverage on Galapagos NV (NASDAQ: GLPG) with a Outperform rating with a EUR61 price target.
Analyst Vamil Divan, "We view Galapagos as a leading clinical-stage biotechnology company that is well positioned to deliver strong long-term growth from its proprietary siRNA discovery... More
Cowen Starts Galapagos NV (GLPG) at Outperform
June 8, 2015 6:41 AM EDTCowen initiates coverage on Galapagos NV (NASDAQ: GLPG) with a Outperform rating.
Analyst Phil Nadeau commented, "Galapagos has advanced a broad and deep pipeline into clinical development, with four candidates currently in clinical testing. Filgotinib has produced impressive results in Ph. IIb trials in... More
